Xenetic Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $589 | $593 | $648 | $614 |
Gross Profit | 593 | 648 | 614 | |
EBITDA | -724 | -942 | -1,099 | -499 |
EBIT | -1,109 | |||
Net Income | -688 | -903 | -1,054 | -436 |
Net Change In Cash | 589 | 593 | 648 | 614 |
Free Cash Flow | -383 | -1,001 | -673 | -459 |
Cash | 4,779 | 5,163 | 6,165 | 6,839 |
Basic Shares | 1,542 | 1,542 | 1,541 | 1,541 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,500 | $2,539 | $1,706 | $1,160 |
Gross Profit | 2,500 | 2,539 | 1,679 | 1,125 |
EBITDA | -4,204 | -4,516 | -6,717 | -5,711 |
EBIT | -4,357 | -4,487 | -6,744 | -5,746 |
Net Income | -3,960 | -4,134 | -6,386 | -5,544 |
Net Change In Cash | 2,500 | 2,539 | 1,706 | 1,160 |
Free Cash Flow | -2,817 | -4,114 | -5,146 | -4,738 |
Cash | 6,165 | 8,983 | 13,097 | 18,244 |
Basic Shares | 1,541 | 1,528 | 1,422 | 1,027 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.45 |
2025-03-31 | -$0.59 |
2024-12-31 | -$0.68 |
2024-09-30 | -$0.28 |
